Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients

Francesca Mallamaci, Carmine Zoccali, Giovanni Tripepi, Isabella Fermo, Francesco A. Benedetto, Alessandro Cataliotti, Ignazio Bellanuova, Lorenzo Salvatore Malatino, Armando Soldarini

Research output: Contribution to journalArticle

257 Scopus citations

Abstract

Background. We prospectively tested the prediction power of homocysteinemia for all-cause and cardiovascular outcomes in a cohort of 175 hemodialysis patients followed for 29 ± 12 months. Methods. Survival analysis was performed by the Cox's proportional hazard model and data were expressed as hazard ratio and 95% confidence interval (CI). Results. During the follow-up period 51 patients died, 31 of them (61%) of cardiovascular causes and 16 patients developed non-fatal atherothrombotic complications. Plasma total homocysteine was an independent predictor of cardiovascular mortality (P = 0.01). Combined analysis of fatal and non-fatal atherothrombotic events showed that homocysteine was a strong and independent predictor of these outcomes because the risk of these events was 8.2 times higher (95% CI 1.9 to 32.2) in patients in the third homocysteine tertile than in those in the first tertile (P = 0.005). Conclusions. There is a clear association between hyperhomocysteinemia and incident cardiovascular mortality and atherothrombotic events in hemodialysis patients. Intervention studies are needed to determine whether the accumulation of this substance has a causal role in the pathogenesis of cardiovascular damage in patients undergoing hemodialysis.

Original languageEnglish (US)
Pages (from-to)609-614
Number of pages6
JournalKidney international
Volume61
Issue number2
DOIs
StatePublished - Jan 1 2002

Keywords

  • Arteriovenous disease
  • Blood pressure
  • Cardiovascular risk
  • Dialysis
  • Homocysteine
  • Mortality study
  • Thrombosis

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients'. Together they form a unique fingerprint.

  • Cite this

    Mallamaci, F., Zoccali, C., Tripepi, G., Fermo, I., Benedetto, F. A., Cataliotti, A., Bellanuova, I., Malatino, L. S., & Soldarini, A. (2002). Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney international, 61(2), 609-614. https://doi.org/10.1046/j.1523-1755.2002.00144.x